Biography and Research Information
OverviewAI-generated summary
Nagalo Bolni's research focuses on the intersection of immunology and oncology, specifically investigating the potential of live attenuated vaccines in cancer treatment. Their recent work explores how the measles, mumps, and rubella (MMR) vaccine can modulate immune cell infiltration within tumors. This research aims to determine if MMR vaccination can enhance the effectiveness of standard cancer therapies, thereby prolonging survival in preclinical models of hepatocellular carcinoma (HCC). Bolni collaborates with researchers at the University of Arkansas for Medical Sciences, including Bahaa Mustafa, Steven R. Post, Martin J. Cannon, and Mulu Z. Tesfay, with whom they share publications.
Metrics
- Publications: 3
Selected Publications
-
Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models (2025)
Collaboration Network
Top Collaborators
Mulu Z. Tesfay
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Aleksandra Cios
University of Arkansas for Medical Sciences (US)
1 shared publication
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Khandoker Usran Ferdous
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Randal S. Shelton
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Bahaa Mustafa
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Camila Simões
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Steven R. Post
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Thomas J. Kelly
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Moaven Moaven
Louisiana State University Health Sciences Center New Orleans (US)
1 shared publication
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Lewis R. Roberts
Mayo Clinic in Arizona (US)
1 shared publication
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Mitesh J. Borad
Mayo Clinic in Arizona (US)
1 shared publication
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Martin J. Cannon
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Alexei G. Basnakian
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 945: Live attenuated MMR vaccines modulate tumor immune cell infiltration and synergize with standard of care to prolong survival in preclinical HCC models
Similar Researchers
Based on overlapping research topics
Mika Taylor
University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers
Liver Disease Diagnosis and Treatment
Cancer Treatment and Pharmacology
Martin J. Cannon
University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers
Immune Cell Function and Interaction
Cancer Treatment and Pharmacology
Alicia L. Graham
University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers
Liver Disease Diagnosis and Treatment
Cancer Treatment and Pharmacology
Teresa Evans
University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers
Vaccine Coverage and Hesitancy
Cancer Treatment and Pharmacology
Behjatolah Monzavi‐Karbassi
University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers
Vaccine Coverage and Hesitancy
Cancer Treatment and Pharmacology
Amir Mahari
University of Arkansas at Fayetteville
Cancer Immunotherapy and Biomarkers
Immune Cell Function and Interaction